Follow
Circulating Tumor DNA (ctDNA)
Circulating Tumor DNA (ctDNA): is tumor-derived fragmented DNA in the bloodstream that is not associated with cells.
-
APR 02, 2024 | 8:00 AM
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have each gained attention as promising liquid biopsy markers, offering molecular insights into cancer progression, overall s...NOV 30, 2023 | 12:00 PMC.E. CREDITS
Pathology Perspective: Discover the critical need for genomic testing in cancer and explore the differences between traditional tissue biopsies and liquid genomic profiling. We'll dive i...Speaker: Dr. Shuko Harada , Dr. Aakash Desai, MBBS, MPHPresented at: Precision Medicine in Solid Tumors
JUN 27, 2023 | 11:00 AMC.E. CREDITS
Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths, according to the World Health Organization. Many cancers can be cu...JUN 15, 2023 | 7:00 AM
Liquid biopsies represent a transformation in the management of cancer as they have the potential to detect, characterize, and monitor cancers earlier than can be achieved with conventional...MAR 30, 2023 | 12:05 PM
In this study, we evaluated the concordance of targeted sequencing results between paired ctDNA and tumor samples from early breast cancers scheduled for curative surgery with or without adj...Speaker: Dr. Chi-Cheng Huang, PhDPresented at: OncomineWorld 2023: A Virtual NGS Education Meeting
MAR 30, 2023 | 12:05 PM
In this study, we evaluated the concordance of targeted sequencing results between paired ctDNA and tumor samples from early breast cancers scheduled for curative surgery with or without adj...Speaker: Dr. Chi-Cheng Huang, PhDPresented at: OncomineWorld 2024: A Virtual NGS Education Meeting
FEB 24, 2022 | 8:00 AM
Date: February 24, 2022 Time: 08:00am (PST), 11:00am (EST) Fume hoods are often the largest consumers of energy in a lab space and are consequent...MAY 14, 2020 | 6:40 PM
Genomic profiling of liquid biopsies is no longer an emerging area of clinical research, but quickly becoming translated as part of contemporary clinical trials for potential future use in t...MAY 14, 2020 | 6:40 PM
Genomic profiling of liquid biopsies is no longer an emerging area of clinical research, but quickly becoming translated as part of contemporary clinical trials for potential future use in t...APR 10, 2019 | 12:00 PM
Determining which patients would derive clinical benefit from immunotherapy is a compelling clinical question. Biomarkers have been shown to predict therapy outcome in various types of cancer...FEB 23, 2017 | 12:00 PM
Despite vast investment for decades in cancer research and development, cancer is still among the leading causes of death worldwide and its toll is expected to rise by about 70% over the next...FEB 23, 2017 | 6:00 AM
Liquid Biopsies are gaining acceptance in the Oncology community as a surrogate or complement to the gold standard of tissue biopsy. A liquid biopsy provides biomarker information that...JAN 19, 2017 | 8:00 AM
DATE: January 19th, 2017TIME: 8:00AM PT, 11:00AM ETLiquid biopsies have the potential to be a less invasive method than traditional biopsies to detect advanced solid tumor mutational st...APR 06, 2016 | 6:00 AM
The advent of personalized medicine employing molecular targeted therapies has markedly changed the treatment of cancer in the past 10 years. Although tumor tissue biopsy-based genotyping is...
APR 02, 2024 | 8:00 AM
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have each gained attention as promising liquid biopsy markers, offering molecular insights into cancer progression, overall s...
NOV 30, 2023 | 12:00 PM
C.E. CREDITS
Pathology Perspective: Discover the critical need for genomic testing in cancer and explore the differences between traditional tissue biopsies and liquid genomic profiling. We'll dive i...
Speaker:
Dr. Shuko Harada
, Dr. Aakash Desai, MBBS, MPH
Presented at: Precision Medicine in Solid Tumors
JUN 27, 2023 | 11:00 AM
C.E. CREDITS
Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths, according to the World Health Organization. Many cancers can be cu...
JUN 15, 2023 | 7:00 AM
Liquid biopsies represent a transformation in the management of cancer as they have the potential to detect, characterize, and monitor cancers earlier than can be achieved with conventional...
MAR 30, 2023 | 12:05 PM
In this study, we evaluated the concordance of targeted sequencing results between paired ctDNA and tumor samples from early breast cancers scheduled for curative surgery with or without adj...
Speaker:
Dr. Chi-Cheng Huang, PhD
Presented at: OncomineWorld 2023: A Virtual NGS Education Meeting
MAR 30, 2023 | 12:05 PM
In this study, we evaluated the concordance of targeted sequencing results between paired ctDNA and tumor samples from early breast cancers scheduled for curative surgery with or without adj...
Speaker:
Dr. Chi-Cheng Huang, PhD
Presented at: OncomineWorld 2024: A Virtual NGS Education Meeting
FEB 24, 2022 | 8:00 AM
Date: February 24, 2022 Time: 08:00am (PST), 11:00am (EST) Fume hoods are often the largest consumers of energy in a lab space and are consequent...
MAY 14, 2020 | 6:40 PM
Genomic profiling of liquid biopsies is no longer an emerging area of clinical research, but quickly becoming translated as part of contemporary clinical trials for potential future use in t...
MAY 14, 2020 | 6:40 PM
Genomic profiling of liquid biopsies is no longer an emerging area of clinical research, but quickly becoming translated as part of contemporary clinical trials for potential future use in t...
APR 10, 2019 | 12:00 PM
Determining which patients would derive clinical benefit from immunotherapy is a compelling clinical question. Biomarkers have been shown to predict therapy outcome in various types of cancer...
FEB 23, 2017 | 12:00 PM
Despite vast investment for decades in cancer research and development, cancer is still among the leading causes of death worldwide and its toll is expected to rise by about 70% over the next...
FEB 23, 2017 | 6:00 AM
Liquid Biopsies are gaining acceptance in the Oncology community as a surrogate or complement to the gold standard of tissue biopsy. A liquid biopsy provides biomarker information that...
JAN 19, 2017 | 8:00 AM
DATE: January 19th, 2017TIME: 8:00AM PT, 11:00AM ETLiquid biopsies have the potential to be a less invasive method than traditional biopsies to detect advanced solid tumor mutational st...
APR 06, 2016 | 6:00 AM
The advent of personalized medicine employing molecular targeted therapies has markedly changed the treatment of cancer in the past 10 years. Although tumor tissue biopsy-based genotyping is...